Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Merck Serono extends fertility franchise

Country: Germany

Merck Serono has extended its reproductive health franchise to include rights to three in vitro fertilization (IVF) products developed by Genea Biomedx Ltd of Australia. The financial terms of the collaboration were not disclosed.

Read more

PureTech to launch London IPO

Country: United States

In a reversal of a recent trend, Boston-based PureTech Health Plc is planning to launch an initial public offering of shares on the London Stock Exchange with the intention of raising $160 million. In recent months, most life science IPOs have taken place in the US.

Read more

Commentary: Circassia offers shares to fund acquisitions

Country: United Kingdom

Read more

Roche says alectinib shrank tumours

Country: Switzerland

Read more

Juno acquires Stage Cell Therapeutics

Country: Germany

Read more

Pfizer invests in AM-Pharma

Country: Netherlands

Read more

Gilead acquires Danish epigenetics company

Country: United States

Read more

Adaptimmune turns to US for an IPO

Country: United Kingdom

Read more

Lundbeck reports flat first quarter revenue

Country: Denmark

Read more

MorphoSys acquires Lanthio Pharma

Country: Germany

Read more

Juno teams up with Fate

Country: United States

Read more

GSK profit declines as strategy shifts

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The next step for immuno-oncology

Next step for CancerImmunotherapyMay2015.pdf

Highlights of the May 2015 MedNous issue

The May 2015 MedNous features:

Latest Mednous cover
  • Business Strategy
    The next step for
    immuno-oncology
  • Oncology Research
    Finding the genetic
    mistakes that fuel cancer
    Interview with Nicholas McGranahan
  • Commentary
    Assessing regulatory T cells as therapy
    By Arnaud Foussat
  • Commentary
    Looking beyond biotech share values
    by Martin Gouldstone
  • Commentary
    Can R&D strategy meet societal needs?
    By Robin Davison

The latest MedNous journal. Subscribe to download.